← Back to Search

Abdominal Binder + Step Counter for Recovery After Gynecologic Surgery (ABS Trial)

N/A

Waitlist Available

Led By Charles Ascher-Walsh, MD

Research Sponsored by Icahn School of Medicine at Mount Sinai

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients undergoing benign hysterectomy or myomectomy via low-transverse laparotomy.

Female

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 24 hours (post-operative day one)

Awards & highlights

No Placebo-Only Group

Summary

This trial will investigate whether abdominal binders help people heal after gynecologic surgery by reducing pain and making it easier to walk.

Who is the study for?

This trial is for English-speaking women who are undergoing benign hysterectomy or myomectomy through a low-transverse laparotomy. It's designed to see if wearing an abdominal binder helps with walking and healing after surgery.

What is being tested?

The study is testing whether using an abdominal binder, which provides support to the abdomen, can improve mobility and aid recovery post-gynecologic surgery. Participants will also use a step counter to track their walking progress.

What are the potential side effects?

While not explicitly stated, potential side effects of using an abdominal binder may include discomfort, skin irritation, or restricted breathing if too tight. Step counters have no known side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am having a surgery for non-cancerous reasons through a low horizontal cut in my abdomen.

Select...

I am female.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ two weeks (until post-operative appointment when step counter is returned)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~two weeks (until post-operative appointment when step counter is returned)

This trial's timeline: 3 weeks for screening, Varies for treatment, and two weeks (until post-operative appointment when step counter is returned) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Daily step counts

Secondary study objectives

Narcotic utilization

Number of participants who thinks there was a benefit

Time to Ambulation

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: ControlExperimental Treatment1 Intervention

This group of patients will not wear abdominal binders, but during this time they will wear a step counter and track their steps. This step counter will be returned at the time of their two week visit.

Group II: Abdominal BinderExperimental Treatment2 Interventions

During this time they will wear a step counter and track their steps. This step counter will be returned at the time of their two week visit.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor

914 Previous Clinical Trials

570,794 Total Patients Enrolled

Charles Ascher-Walsh, MD4.031 ReviewsPrincipal Investigator - Icahn School of Medicine at Mount Sinai

Icahn School of Medicine at Mount Sinai

4 Previous Clinical Trials

326 Total Patients Enrolled

5Patient Review

Dr. Ascher-Walsh was very understanding and informative when I had my consultation with him. He explained my situation in a way that was easy to understand, and he made sure that I had all the information I needed to make a decision about my care. I'm very grateful to him for everything.